Medical/Pharmaceuticals
Lupin Completes Acquisition of VISUfarma
MUMBAI, India and LONDON and ROME and ZUG, Switzerland, April 2, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) announced the completion of its acquisition of VISUfarma B.V. (VISUfarma), a leading European specialty...
Free Tickets Open for 2026 Medtec
SHANGHAI, April 2, 2026 /PRNewswire/ -- Free tickets for 2026 Medtec open on April 1, 2026. Visitors who complete registration before August 31 can enter free of charge. AsAsia's Leading Medical Device Supply Chain Expo — From R&D to Commercial Manufacturing, 2026 Medtec will be held from Septemb...
Telix Appoints David Gill as Non-Executive Director
MELBOURNE, Australia and INDIANAPOLIS, April 2, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces the appointment of David Gill as a Non-Executive Director (NED), as part of Board expansion and succession planning. The appointment is effective May...
NCCN 2026 Annual Conference Prepares Cancer Care Providers Worldwide for Healing the Whole Patient
Pressing issues in oncology, including rising cancer incidences in younger people, plus global opportunities for improving outcomes, were presented alongside cutting-edge research and clinical guidelines updates, during yearly event hosted by the National Comprehensive Cancer Network. ORLANDO, F...
Alphamab Oncology Announces the Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 as Neoadjuvant Treatment for Breast Cancer Has Met the Primary Endpoint
SUZHOU, China, April 1, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that HER2 bispecific antibody Anbenitamab Injection (KN026), independently developed by the Company, and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharmaceu...
PATIENT TRUST AND QUALITY CARE DRIVE MALAYSIA'S GROWING HEALTHCARE REPUTATION
KUALA LUMPUR, Malaysia, April 1, 2026 /PRNewswire/ -- As Malaysia's healthcare ecosystem continues to strengthen its reputation for quality and innovation, Pantai Hospital Kuala Lumpur (PHKL), part of the IHH Healthcare multinational network has been recognised as one of the World's Best Hospital...
NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development
PRINCETON, N.J. and TOKYO, April 1, 2026 /PRNewswire/ -- NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma Services ("Aji Bio‑Pharma"), a leading provider of biopharmaceutical manufacturing services and platform technologies...
Dalton Pharma Services Expands Aseptic Powder Fill-Finish Capacity with RoboFil™ system in Toronto
A fully automated aseptic fill-finish platform delivers greater speed, flexibility, and quality for the manufacturing of clinical supplies and commercial products. TORONTO, March 31, 2026 /PRNewswire/ -- Dalton Pharma Services today announced the successful installation of its RoboFil™ aseptic p...
Gan & Lee Pharmaceuticals' Once-Weekly Basal Insulin GZR4 Injection Meets Primary Endpoints in Two Pivotal Phase 3 Clinical Trials: SUPER-1 and SUPER-2
BEIJING and BRIDGEWATER, N.J., March 31, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals (SSE: 603087) today announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 Injection, have successfully met their pre-specified primary endpo...
Inaugural Rabies in Asia Conference to Be Held in Kuching
KUCHING, Malaysia, March 31, 2026 /PRNewswire/ -- Place Borneo Sdn Bhd, in collaboration with the Department of Veterinary Services Sarawak (DVSS), will host the 1st Rabies in Asia (RIA) 2026 in conjunction with the 5th Rabies in Borneo (RIB) 2026, taking place 29 September to 1 October 2026 at t...
LabConnect Launches SampleGISTICS® 2.0 to Digitize Clinical Trial Sample Capture
Smartphone-based solution streamlines site workflows and enables real-time
visibility at the sample level
RALEIGH, N.C., March 31, 2026 /PRNewswire/ -- LabConnect
3SBio Announces 2025 Annual Results: Dual Engines of Innovative R&D and Global Collaboration Propel Revenue Past RMB 10 Billion Milestone
SHANGHAI, March 31, 2026 /PRNewswire/ -- 3SBio Inc. (01530.HK
SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD
TAMPA, Fla., March 31, 2026 /PRNewswire/ -- Concept Medical Inc.
DNV SELECTED TO CERTIFY CLASS D DEVICES FOR LEADING U.S. MANUFACTURER UNDER EU IVDR
DNV supports the manufacturer's transition to new regulation with its digital certification platform and transparent, predictable project management. OSLO, Norway, March 31, 2026 /PRNewswire/ -- DNV, a designated Notified Body for the European Union's In Vitro Diagnostic Regulation (IVDR) and Med...
4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union
In a separate announcement made today, the Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion. MELBOURNE, Australia, March 31, 2026 /PRNewswire/ -- 4DMedical Limited (ASX:4DX), the global leader in cardiothoracic imaging s...
CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: "Smaller Incisions, Faster Recovery"
* Korea–Thailand spine experts jointly lead advanced training on endoscopic spine surgery and lateral lumbar interbody fusion techniques * Hands-on experience with Korean spine medical devices lays the foundation for advancing Asia's spine education hub SEOUL, South Korea and BANGKOK, March 3...
IFPA launches first Africa Forum on psoriasis calling for urgent action on overlooked disease
Nairobi event takes place May 7-9 STOCKHOLM, March 30, 2026 /PRNewswire/ -- IFPA (The International Federation of Psoriasis Associations) – is convening the first-ever regional summit dedicated exclusively to psoriasis in Africa - one of the continent's most underrecognized chronic diseases. ...
Qyuns Therapeutics-B (02509) 2025 Revenue Surges Over 4-Fold; Adjusted Profit Reaches Approximately RMB356 Million, Turning a Profit Year-on-Year
TAIZHOU, China, March 30, 2026 /PRNewswire/ -- Qyuns Therapeutics-B (02509) announced its 2025 annual results. Revenue amounted to approximately RMB807 million, representing a 4.08-fold year-on-year increase. Gross profit reached approximately RMB714 million, a 6.75-fold increase year-on-year. Pr...
Organon accelerates Women's Health progress across Asia Pacific with 2026 Her Health Grants
SYDNEY, March 30, 2026 /PRNewswire/ -- Organon Asia Pacific Cluster today announced the 2026 Her Health Grant recipients for the Asia Pacific region, marking a significant milestone in efforts to strengthen and expand women's health initiatives across the region. The Her Health Grants are design...
Foshan Launches First Provincial-Level International Medical Pilot
Foshan Fosun Chancheng Hospital Sets New Benchmark for Greater Bay Area Healthcare FOSHAN, China, March 29, 2026 /PRNewswire/ -- On March 28, Foshan Fosun Chancheng Hospital inaugurated the International Medical Center (FIMC), Foshan's first provincial-level international medical pilot, supporti...
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 305 media titles]
2026-05-19 18:10Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 302 media titles]
2026-05-19 23:59Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
[Picked up by 293 media titles]
2026-05-15 17:00Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 289 media titles]
2026-05-18 15:30AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity
[Picked up by 279 media titles]
2026-05-19 14:00